Aegon NV (NL:AGN)
:AGN
Want to see NL:AGN full AI Analyst Report?
Top Page
Aegon NV
(AGN)
Select Model
Select Model
Rating:58Neutral
Price Target:
€7.00
▲(0.86% Upside)
Action:ReiteratedDate:03/28/26
The score is driven by improving but still volatile financial performance (profits recovering, debt down, but uneven revenue and cash-flow consistency). Valuation is a major positive due to the very low P/E and high dividend yield, while technical signals are a notable drag with the stock trading below key moving averages and negative MACD.
Positive Factors
Profit recovery & 2025 revenue rebound
Aegon’s return to net profitability in 2024–2025 and a strong 2025 revenue rebound indicate the firm can restore underwriting and operational performance after loss years. This durable earnings recovery improves capacity to fund liabilities, support distributions, and reinvest in core insurance and retirement franchises over the medium term.
Negative Factors
Multi-year revenue and earnings volatility
Aegon’s history of sharp revenue and earnings swings reduces predictability of underwriting margins and fee income, complicating capital planning and product pricing. For an insurer, persistent volatility undermines confidence in sustainable profitability and makes long-term funding of guarantees and pensions harder to manage.
Read all positive and negative factors
Positive Factors
Negative Factors
Profit recovery & 2025 revenue rebound
Aegon’s return to net profitability in 2024–2025 and a strong 2025 revenue rebound indicate the firm can restore underwriting and operational performance after loss years. This durable earnings recovery improves capacity to fund liabilities, support distributions, and reinvest in core insurance and retirement franchises over the medium term.
Read all positive factors
Aegon NV (AGN) vs. iShares MSCI Netherlands ETF (EWN)
Market Cap
€10.23B
Dividend Yield5.79%
Average Volume (3M)5.38M
Price to Earnings (P/E)10.6
Beta (1Y)1.08
Revenue Growth-6.64%
EPS GrowthN/A
CountryNL
Employees15,582
SectorGeneral
Sector StrengthN/A
IndustryInsurance - Diversified
Share Statistics
EPS (TTM)0.23
Shares Outstanding1,573,119,900
10 Day Avg. Volume5,483,647
30 Day Avg. Volume5,375,044
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)1.38
Price to Sales (P/S)0.31
P/FCF Ratio11.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€7.37Price Target Upside6.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)0.8
Revenue Forecast (FY)€21.01B
Aegon NV Business Overview & Revenue Model
Company Description
Aegon N.V. provides insurance, pensions, and asset management services in the Americas, the Netherlands, and the United Kingdom. The company offers life, accident, and health insurance; savings, pension, annuities, and mutual funds; property and c...
How the Company Makes Money
Aegon makes money primarily by earning (1) insurance and retirement-related income from writing and servicing long-term contracts and (2) fees from managing assets and administering investment/retirement accounts. For its life insurance and annuit...
Aegon NV Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
58
Neutral
Cash Flow
49
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 33.40B | 19.52B | 29.54B | 53.77B | 46.14B |
| Gross Profit | 33.40B | 19.52B | 22.88B | -15.85B | 46.14B |
| EBITDA | 1.22B | 635.00M | -204.00M | 1.00B | 2.21B |
| Net Income | 977.00M | 688.00M | -179.00M | -570.00M | 1.98B |
Balance Sheet | |||||
| Total Assets | 317.23B | 327.39B | 301.58B | 401.79B | 468.25B |
| Cash, Cash Equivalents and Short-Term Investments | 3.19B | 58.18B | 4.07B | 64.31B | 108.25B |
| Total Debt | 5.61B | 5.00B | 4.92B | 6.67B | 12.23B |
| Total Liabilities | 309.62B | 318.08B | 292.03B | 387.60B | 441.88B |
| Stockholders Equity | 7.53B | 9.19B | 7.55B | 14.01B | 26.18B |
Cash Flow | |||||
| Free Cash Flow | 887.00M | 711.00M | 748.00M | 2.75B | -1.91B |
| Operating Cash Flow | 928.00M | 762.00M | 864.00M | 2.85B | -1.80B |
| Investing Cash Flow | 580.00M | 300.00M | -2.00B | 616.00M | -54.00M |
| Financing Cash Flow | -2.00B | -1.75B | -3.24B | -1.92B | 300.00M |
Aegon NV Technical Analysis
Positive
6.94
Price Trends
6.37
Positive
6.50
Positive
6.47
Positive
Market Momentum
0.18
Negative
73.96
Negative
91.47
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:AGN, the sentiment is Positive. The current price of 6.94 is above the 20-day moving average (MA) of 6.42, above the 50-day MA of 6.37, and above the 200-day MA of 6.47, indicating a bullish trend. The MACD of 0.18 indicates Negative momentum. The RSI at 73.96 is Negative, neither overbought nor oversold. The STOCH value of 91.47 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NL:AGN.
Aegon NV Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | €15.61B | 5.57 | 11.85% | 2.07% | 2.01% | 79.48% | |
60 Neutral | €71.14B | 12.40 | 12.05% | 5.10% | 0.12% | -2.71% | |
58 Neutral | €10.23B | 10.61 | 14.36% | 5.79% | -6.64% | ― | |
57 Neutral | €24.98B | 14.95 | 9.85% | 4.36% | -12.70% | -12.34% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | €13.20B | 6.94 | 6.31% | 5.32% | 16.35% | 67.44% | |
53 Neutral | €18.37B | ― | 6.47% | 5.40% | -15.54% | 10.53% |
* General Sector Average
NL:AGN
Aegon NV
6.94
1.88
37.11%
NL:ABN
ABN AMRO Group N.V.
30.52
13.61
80.43%
NL:ASRNL
ASR Nederland N.V
64.40
14.41
28.83%
NL:HAL
HAL Trust
171.40
59.92
53.74%
NL:INGA
ING GROEP
24.67
9.71
64.87%
NL:NN
NN Group N.V.
73.56
25.00
51.47%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.